ACADIA Pharmaceuticals Inc. vs Cognizant Technology Solutions Corp — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Cognizant Technology Solutions Corp trades at $57.84 (market cap $26.40B). The key difference: Cognizant Technology Solutions Corp is far larger — about 5.2× ACADIA Pharmaceuticals Inc.'s market cap, and Cognizant Technology Solutions Corp pays a 2.25% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | CTSH | |
|---|---|---|
Market Cap | $5.07B | $26.40B |
Sector | Health | Technology |
52-Week High | $29.41 | $86.70 |
52-Week Low | $20.06 | $38.73 |
Enterprise Value | $4.19B | $27.44B |
Dividend Yield | — | 2.25% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
Read more on CTSH →